28 million doses have been ordered from the Sanofi laboratory, 50 million from the GSK laboratory and 16 million from the Novartis laboratory. 34 million optional doses have been ordered, including 28 million from the Sanofi laboratory, and 6 million from Novartis. These optional doses should be delivered in 2010, in case the circulation of the H1N1 virus in France is very active.
The vaccines should be delivered in the fall, “between October and December”, according to Roselyne Bachelot, after marketing authorization. They should consist of two doses per person, injected two weeks apart. They will be reimbursed by Social Security and mutual funds, and will be injected by the attending physician.
People at risk will then be given priority, that is to say those under 65 and pregnant women, as well as those under 18. A vaccine for infants under 1 year of age could also be given as a priority, although the existence of this type of vaccine is not very likely at the moment.
From July 23, people with influenza will not be directly directed to centers 15 or hospitals as is currently the case. Liberal doctors will then be able to examine these affected people.
